openPR Logo
Press release

Biomarkers Market 2025-2032: Precision Healthcare and Next-Gen Research Tools | Most Leading Companies - Thermo Fisher Scientific Inc., QIAGEN NV, Merck KGaA, BRUKER CORPORATION

06-18-2025 09:01 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Biomarkers Market

Biomarkers Market

The Global Biomarkers Market reached US$ 60.76 billion in 2024 and is expected to reach US$ 148.88 billion by 2032, growing at a CAGR of 11.9% during the forecast period 2025-2032.

The Biomarkers Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.

Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/biomarkers-market?kb

Biomarkers Market Overview

Biomarkers are measurable indicators of biological processes, conditions, or diseases used in diagnosis, prognosis, and therapy monitoring.

Research Methodology:

The global Biomarkers Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.

Segment Covered in the Biomarkers Market:

By Product Type: Diagnostic Biomarkers, Monitoring Biomarkers, Predictive Biomarkers, Susceptibility/Risk Biomarkers, Prognostic Biomarkers, Pharmacodynamic/Response Biomarkers, Safety Biomarkers, Others

By Application: Drug Discovery and Development, Disease Diagnostics, Disease Risk Assessment, Personalized Medicine, Others) By End-User (Pharmaceutical Companies, Biotechnology Companies, Research Centers and Institutes, Others

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/biomarkers-market?kb

List of the Key Players in the Biomarkers Market:

Thermo Fisher Scientific Inc., QIAGEN NV, Merck KGaA, BRUKER CORPORATION, Bio-Rad Laboratories, Inc., Siemens Healthineers AG, Abbott Laboratories, Agilent Technologies Inc., Myriad Genetics and Somru BioScience Inc. among others.

Industry Development:

In July 2024, Scipher Medicine, known for its proprietary AI and network biology platform aimed at revolutionizing patient care, introduced an innovative approach to biomarker development. This followed the release of PRoBeNet (Predictive Response Biomarkers using Network Medicine), a novel, patent-pending framework designed to identify predictive biomarkers through network medicine.

In October 2023, Mindray expanded its cardiovascular diagnostics portfolio with the launch of high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. These additions strengthen the company's offerings for the effective diagnosis and management of cardiovascular diseases (CVDs).

Regional Analysis for Biomarkers Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Go-to-market Strategy.

➡ Neutral perspective on the market performance.

➡ Customized regional/country reports as per request and country level analysis.

➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➠ What are the global sales, production, consumption, imports, and exports in the Biomarkers market?

➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?

➠ What key opportunities and challenges do vendors face in the Biomarkers industry?

➠ Which product types, applications, or end-users are driving market growth, and what is their market share?

➠ What are the major growth drivers and restraints of the Biomarkers market?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market 2025-2032: Precision Healthcare and Next-Gen Research Tools | Most Leading Companies - Thermo Fisher Scientific Inc., QIAGEN NV, Merck KGaA, BRUKER CORPORATION here

News-ID: 4071622 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Grant Management Software Market Set to Reach USD 3.3 Billion by 2030, Fueled by Strategic Consolidation and AI-Led Digital Transformation | DataM Intelligence
Grant Management Software Market Set to Reach USD 3.3 Billion by 2030, Fueled by …
The Global Grant Management Software Market, valued at US$ 1.5 billion in 2022, is projected to grow at a CAGR of 10.3% to reach US$ 3.3 billion by 2030. The market is experiencing robust growth driven by strategic industry consolidation, the acceleration of digital transformation across public and private sectors, and the mainstream integration of artificial intelligence to automate complex workflows and enhance decision-making. Get a Free Sample PDF Of This
Ceramic Adhesives Market Set for Steady Growth to USD 11.2 Billion by 2030, Fueled by Construction Boom in Asia-Pacific | DataM Intelligence
Ceramic Adhesives Market Set for Steady Growth to USD 11.2 Billion by 2030, Fuel …
The Global Ceramic Adhesives Market reached US$ 7.5 billion in 2022 and is expected to reach US$ 11.2 billion by 2030, growing at a CAGR of 5.1% during the forecast period 2023-2030. This sustained growth is driven primarily by the rapid expansion of the construction industry worldwide, which demands durable and reliable bonding solutions for tile installation, flooring, and wall cladding. The shift towards high-performance adhesives with superior strength and
Automotive Elastomers Market Poised for Steady Growth to USD 51.4 Billion by 2030, Driven by Lightweighting and Electrification Trends | DataM Intelligence
Automotive Elastomers Market Poised for Steady Growth to USD 51.4 Billion by 203 …
The Global Automotive Elastomers Market reached US$ 32.5 billion in 2022 and is expected to reach US$ 51.4 billion by 2030, growing at a CAGR of 5.3% during the forecast period 2023-2030. This sustained growth is propelled by the global automotive industry's relentless pursuit of vehicle lightweighting to improve fuel efficiency and meet emissions regulations, the rising adoption of electric vehicles (EVs) requiring specialized components, and the superior performance of
Plant-Based Ice Cream Market Scoops Up Growth to Reach USD 1.83 Billion by 2032, Fueled by Health Trends and Dairy Alternatives Demand in North America | DataM Intelligence
Plant-Based Ice Cream Market Scoops Up Growth to Reach USD 1.83 Billion by 2032, …
The Global Plant-Based Ice Cream Market reached US$ 1.05 billion in 2024 and is projected to reach US$ 1.83 billion by 2032, growing at a CAGR of 7.21% during the forecast period 2025-2032. This robust growth is propelled by a significant increase in the vegan population, heightened consumer health consciousness regarding lactose intolerance and cholesterol, and a powerful shift in dietary preferences toward sustainable, dairy-free alternatives, with North America leading

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out